Beijing State-owned Capital Operation and Management
北京国管
elsewhere's corpus doesn't carry a full profile of Beijing State-owned Capital Operation and Management (北京国管). What it does show is the entity acting as an LP: in C-Bridge Capital's buyout fund first close of over RMB 7 billion, 北京国管 was the lead investor in the first tranche with RMB 3.467 billion committed, per 暗涌Waves' March 2025 report . Beyond that, elsewhere has no material on its background, scale, or mandate.
AI-generated — may contain errors, please verify.
Coverage
Inno Pharmaceuticals Completes Nearly RMB 800 Million Series D Funding to Accelerate Global Multicenter Clinical Development of Precision Targeted Drugs
The company has pioneered a proprietary active-targeting liposomal drug delivery platform, underpinning an innovative drug pipeline that spans multiple serious disease areas, including cardiovascular and cerebrovascular diseases and glioblastoma.
Where Are the Bold State Investors?
Breaking Down the Most Active Local State-Owned Capital.
C-Bridge Capital Closes First Close of Over RMB 7 Billion Buyout Fund, Fu Wei's "Minority" Path
Over the past decade, CBC Group has risen from obscurity to manage 65 billion yuan in assets.
